Gender differences and the effects of ketamine in healthy volunteers

Journal of Psychopharmacology

Volumn 18, Issue 3, 2004, Pages 337-339

  Lees, Jane ^a   Hallak, Jaime E C ^a   Deakin, John F W ^a   Dursun, Serdar M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Gender; Ketamine; Oestrogen; Psychosis; Schizophrenia

Indexed keywords

ESTROGEN; KETAMINE;

DISEASE COURSE; ESTROGEN BLOOD LEVEL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SEX ROLE;

ANIMALS; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; KETAMINE; MALE; PSYCHOSES, SUBSTANCE-INDUCED; RATS; SEX FACTORS;

EID: 6044260210     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110401800302     Document Type: Review

References (26)

1. Abel K M, Allin M, Geyer M (2000) Subanaesthetic ketamine in healthy male volunteers: effects of sensorimotor gating, cognitive performance and perception. Schizophr Res 41: 236
2. Abel K M, Allin M P, Hemsley D R, Geyer M A (2003) Low dose ketamine increases prepulse inhibition in healthy men. Neuropharmacology 44: 729-737
3. Adler C M, Goldberg T E, Malhotra A K, Pickar D, Breier A (1998) Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43: 811-816
4. Aleman A, Kahn R S, Selten J P (2003) Sex differences in the risk of schizophrenia. Arch Gen Psychiatry 60: 565-571
5. Anand A, Charney D S, Oren D A, Berman R M, Hu X S, Cappiello A, Krystal J H (2000) Attentuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutaminergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 57: 270-276
6. Breier A, Malhotra A K, Pinals D A, Weisenfeld N I, Pickar D (1997) Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry 154: 805-811
7. Breier A, Adler C M, Weisenfeld N, Su T P, Elman I, Picken L, Malhotra A K, Pickar D (1998) Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29: 142-147
8. Farber N B, Hanslick J, Kirby C, McWilliams L, Olney J W (1998) Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity. Neuropsychopharmacology 18: 57-62
9. Hetem L A B, Danion J M, Diemunsch P, Brandt C (2000) Effect of subanaesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology 152: 283-288
10. Jansen K L (2000) A review of the non-medical use of ketamine: use, users and consequences. J Psychoact Drugs 32: 419-433
11. Kegeles L S, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann J J, Van Heertum R L, Cooper T B, Carlsson A, Laruelle M (2000) Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry 48: 627-640
12. Krystal J H, Karper L P, Seibyl J P, Freeman G K, Delaney R, Bremner J D, Heninger G R, Bowers M B, Charney D S (1994) Subanaesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214
13. Lahti A C, Weiler M A, Michaelidis T, Parwani A, Tamminga C A (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25: 455-467
14. Malhotra A K, Pinals D A, Weingartner H, Sirocco K, Missar C D, Pickar D, Breier A (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14: 301-307
15. Marie N, Krabbendam L, Vollebergh W, De Graaf R, Van Os J (2002) Sex differences in symptoms of psychosis in a non-selected, general population sample. Schizophr Res 1825: 1-7
16. Micallef J, Guillermain Y, Tardieu S, Hasbroucq T, Possamai C, Jouve E, Blin O (2002) Effects of subanaesthetic doses of ketamine on sensorimotor information processing in healthy subjects. Clin Neuropharmacol 25: 101-106
17. Newcomer J W, Farber N B, Jevtovic-Todorovic V, Selke G, Melson A K, Hershey T, Craft S, Olney J W (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20: 106-118
18. Riecher-Rössler A (2002) Oestrogen effects in schizophrenia and their potential therapeutic implications - review. Arch Women Ment Health 5: 111-118
19. Riecher-Rössler A, Häfner H, Dütsch-Strobel A, Oster M, Stumbaum M, Van Gülick-Bailer M, Löffler W (1994) Further evidence for a specific role of estradiol in schizophrenia? Biol Psychiatry 36: 492-495
20. Sharp F R, Butman M, Aardalen K, Nickolenko J, Nakki R, Massa S M, Swanson R A, Sagar S M (1994) Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics. Psychopharmacol Bull 30: 555-560
21. Sobell J L, Mikesell M J, McMurray C T (2002) Genetics and Etiopathophysiology of Schizophrenia. Mayo Clin Proc 77: 1068-1082
22. Umbricht D, Schmid L, Koller R, Vollenweider F X, Hell D, Javitt D C (2000) Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 57: 1139-1147
23. Umbricht D, Koller R, Vollenweider F X, Schmid L (2002) Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry 51: 400-406
24. Van Berckel B N, Oranje B, Van Ree J M, Verbaten M N, Kahn R S (1998) The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behaviour in healthy human subjects. Psychopharmacology 137: 271-281
25. Weiler M A, Thaker G K, Lahti A C, Tamminga C A (2000) Ketamine effects on eye movements. Neuropsychopharmacology 23: 645-653
26. Winters W D, Hance A J, Cadd G C, Lakin M (1986) Seasonal and sex influences on ketamine-induced analgesia and catalepsy in the rat; a possible role for melatonin. Neuropharmacology 25: 1095-1101